What is KNBIF's gross margin?

Kane Biotech (KNBIF) has a gross margin of -142% and a net margin of -10238%.

What is KNBIF's P/E ratio?

Track Kane Biotech (KNBIF) P/E ratio, ROE, and valuation metrics over time.

Where can I see KNBIF's full financials?

See Kane Biotech (KNBIF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Kane Biotech (KNBIF) Financials — Revenue, Earnings, Cash Flow

Also trades as: KNE.V (TSXV) · $vol 0M

$0.02

-0.00 (-2.79%)

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $3.8M mcap · 105M float · 0.102% daily turnover · Short 73% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$0M

Revenue

-97.9% YoY

$-3M

Net Income

+17.0% YoY

$-2M

Free Cash Flow

+19.2% YoY

-142.5%

Gross Margin

-9683.6%

Op. Margin

-10238.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE439.7%

ROA-89.5%

ROIC-2166.6%

Valuation

P/E-2.1

P/B-6.2

EV/EBITDA0.0

Leverage

Debt/Equity-1.98

Current Ratio0.61

Interest Cov.-17.2x

Quality Scores

Piotroski F2/9

Altman Z—

Beneish M-6.06